For the first time, the ACCC National Oncology Conference is now available on-demand! Experience our inspirational and actionable keynote sessions, 2020 ACCC Innovator Award winner presentations, and facilitated roundtable discussions—from the comfort of your home or office—while earning continuing education credits.
To hear these sessions on-demand, please visit the ACCC eLearning portal.
ACCC 37th [Virtual] National Oncology Conference Kickoff
Welcome remarks by ACCC President Randall A. Oyer, MD, and the opening ceremony for the 2020 ACCC Innovator Award recipients.
Opening Keynote: Leadership Resilience and Post Traumatic Growth & Live Audience Q&A
Greg Hiebert, Leadership Educator, (Coach) and Consultant
Great leaders provide calm, confidence, and courage to their teams and organizations especially during great storms, difficulties, and adversities, certainly like the immense impact COVID-19 has had on our healthcare delivery systems. Whether you are in a leadership position or act as an "informal" leader and/or mentor at your cancer program or practice, learn how to turn difficult experiences into positive learning and growth for yourself and others. Come away with research-based mindsets, skillsets, and toolsets on what leaders can do to help their colleagues, teams and organizations be more resilient and use adversity as a means to be stronger, more clear, focused, determined, compassionate, and capable.
Nadine J. Barrett, PhD, MA, MS, ACCC Board of Trustees Member
Krista Nelson, MSW, LCSW, OSW-C, BCD, ACCC President-Elect
Tune in for a critical conversation with Nadine J. Barrett, PhD, MA, MS and Krista Nelson, MSW, LCSW, OSW-C, BC as they discuss diversity and inclusion for women in oncology, and share their experiences within the field.
Closing Keynote: Addressing the Disparity of Women in Oncology & Live Audience Q&A
Nick Smith-Stanley, MBA, Associate Director of Finance and Administration, Livestrong Cancer Institutes, Dell Medical School
Associate Director of Administration and Strategic Planning
Department of Oncology, Dell Medical School, The University of Texas at Austin
Piloted in 2019, the Summer Healthcare Experience (SHE)is the first of its kind to specifically address the disparity of women in oncology. Learn about development of the SHE program, which hosts juniors and seniors who identify as female to participate in a week-long, immersion program that introduces them to cancer biology, research, and care. Throughout the week, these students also undergo leadership exercises and training that can relate to any field they wish to pursue outside of medicine, based on an underlying theme of overcoming the challenges they will face as women in medicine, oncology, and academics. The innovative curriculum features a combination of teaching methodologies including didactic lectures and interactive and hands-on demonstrations. Hear firsthand from a student who participated in this program about what she learned and how the program impacted her personal and professional growth. Then consider becoming a part of the solution by partnering with your local schools to develop a similar equity initiative at your program or practice.
Facilitated Hot-Topic Roundtable Discussions
Engaging Your Physicians in Clinical Trials
Moderator: Randall Oyer, MD, Oncology Program, Medical Director, Penn Medicine-Lancaster
Revenue Cycle Optimization
Moderator: Christina Fuller, BSW, Oncology Patient Financial Navigator, Mosaic Life Care Cancer Care
Wellness Strategies to Reduce Burnout
Moderator: Rebecca McMahon, Radiation Oncology Manager, Buffett Cancer Hospital, Nebraska Medicine
Developing Effective Cancer Program Leadership
Moderator: Barbara Schmidtman, PhD, Director Oncology Services, Spectrum Health Lakeland
Cultural Humility and Sensitivity in Multidisciplinary Cancer Care
Moderators: Dawn Fisher, Program Specialist, Diversity and Inclusion and Arthur Breese, Director, Diversity and Inclusion, Geisinger Healthcare
Meeting the Unique Needs of AYAs
Moderators: Anne Marie Rainey, MSN, RN, CHC, Compliance and Quality Control Officer and Kristin Donahue, MSN, RN, OCN, Director of Education Services, Clearview Cancer Institute
Ramping Up Cancer Outreach and Prevention Activities In a COVID-19 World
Moderators: Janine Tucker and Griselda Sanchez, Community Outreach Coordinators, Cancer Center Patient Support Services, Froedtert & the Medical College of Wisconsin
Mentoring Those New to Oncology
Moderator: Kerri Michalik, MHA, BSN, Vice President, Cancer Services, Geisinger Health System, Geisinger Cancer Institute
Onboarding Experienced Non-Oncology Nurses to Address Staffing Shortages: Development of a Transitional Oncology Training Academy
Marguerite Rowell, MSN, MBA, MSM/HM, ONC, SCRN, Assistant Vice President of Nursing
Hollie Gow, DNP, APRN, ACNP-BC, CCRN, PCCN CPHQ, Director of Professional Nursing Practice & Performance Improvement
Miami Cancer Institute, Baptist Health South Florida
This 12-week academy at Miami Cancer Institute gives nurses the knowledge and skills they need to successfully transition to radiology, blood and marrow transplant, outpatient infusion oncology, and Phase I/II research on a Precision Medicine Unit. Expert nurses and Master’s-prepared oncology educators provide hands-on orientation to entity-specific policies and procedures; training on core oncology nursing skills, such as central line care and maintenance, port access, safe drug administration, and hazardous spill clean-up; and preparation for the ONS/ONCC Chemotherapy Immunotherapy Certificate. Individualized preceptors work side-by-side with academy nurses upon transition to their units.
This session includes a 30 minute discussion with the Innovator Award winners and the program champion, Michele Ryder, MSN, MSHSA, RN, CENP, Cancer Program Administrator, about the process to procure leadership buy-in and dedicated resources for this program.
Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions
Larry Bilbrey, Care Data Systems Manager
After analysis of Oncology Care Model data identified three comorbid illnesses that led to significantly higher rates of unplanned emergency department (ED) visits and hospitalizations—COPD, congestive heart failure, and diabetes mellitus—Tennessee Oncology developed targeted management algorithms that proactively addressed these conditions. Today care coordinators use these algorithms to screen, identify, and help manage at-risk patients via the care management platform, either by patient-initiated contact, such as telephone triage, or through a patient health portal, depending on the patient’s access and comfort with this technology. For patients admitted to the ED or hospital, admission software provides real-time data to the practice to improve patient management and reduce length of stay and readmissions.
This session includes a 30 minute discussion with the Innovator Award winner and the program champion, Johnetta Blakely, MD, MS, MMHC, Executive Director of Health Economics and Outcome Research; Chairwoman, Performance Improvement Committee, about the process to procure leadership buy-in and dedicated resources for this program.
Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement
Amanda Wright, PharmD, Oncology Pharmacist
St. Luke's Cancer Institute
Learn how a pharmacy resident project supported the creation and implementation of an oral oncolytic collaborative practice agreement (CPA) that expanded pharmacist scope of practice, decreased turnaround time for processing prescriptions, improved provider satisfaction, and decreased patient prescription costs. Today, St. Luke's Cancer Institute’s CPA allows pharmacists to sign prescriptions on behalf of providers for interventions such as renal or hepatic dose adjustments, dose rounding, renewal of prescription refills, adjustment for toxicities, dosing based on appropriate indication, and the ordering of laboratory tests and/or exams.
This session includes a 30 minute discussion with the Innovator Award winner and the program champion, Julia Kerr, PharmD, Medically Integrated Pharmacy Program Coordinator, about the process to procure leadership buy-in and dedicated resources for this program.
Leveraging a 3D Lung Nodule Educational Tool to Reduce Patient Distress
Theresa Roelke, MSN, RN, AGNP-C, Geriatric Nurse Practitioner
Maine Medical Center Cancer Institute
Maine Medical Center Cancer Institute explored use of a 3D-printed nodule tool to help providers educate patients and engage in shared-decision making about this commonly reported lung lesion. Their study goals were twofold: evaluate if the tool reduced patient distress after a lung nodule finding and evaluate if the tool improved patient understanding of lung cancer risk. Data showed that using this type of 3D educational tool as part of shared decision-making facilitates high quality communication, improves patient knowledge about malignancy risk, reduces emotional distress, and improves quality of life. Hear how this type of educational tool can improve patient care at your program or practice.
This session includes a 30 minute discussion with the Innovator Award winner and the program champion, Gary Hochheiser, MD, Director of Thoracic Surgery; Medical Director, MMC Lung Cancer Screening Program; Co-Chair, Maine Health Thoracic Oncology Work Group; Board-Certified Thoracic Surgeon, about the process to procure leadership buy-in and dedicated resources for this program.
A Nurse Navigator-Led Community-Based Cardio-Oncology Clinic
Vijay Rao, MD, PhD, FACC, FASE, FHFSA, Director, CardioOncology; Co-Director, Heart Failure Program and Anti-coagulation Clinic
Kerry Skurka, RN, BSN, Cardio-Oncology Nurse Navigator
Franciscan Health Cancer Center Indianapolis
Hear how this program grew from manual chart mining to identify at-risk patients into a program sustained by robust referrals from providers looking for the specialized expertise of cardio-oncologists. Today Franciscan Health Cancer Center Indianapolis manages the cardio-toxic side effects of more than 1,000 cancer patients. Working in collaboration with medical oncologists and other members of the multidisciplinary team, the cardio-oncology team helps keep oncology patients in treatment and works to improve patient quality of life. Gain additional perspective from an educational video that chronicles a patient’s journey through the clinic.
This session includes a 30 minute discussion with the Innovator Award winners and the program champion, Peter Garrett, MD, FACR, Medical Director of Cancer Services and Radiation Oncology, about the process to procure leadership buy-in and dedicated resources for this program.
Reducing ED Visits and Hospital Admissions after Chemotherapy with Predictive Modeling of Risk Factors
Michelle Smith, DC, Director Oncology Services
Mercy Cancer Care
After conducting a retrospective review to identify clinical variables associated with increased risk of hospital admissions and emergency department visits, Mercy Cancer Care used these data to develop and implement a predictive algorithm that stratifies patients according to their 30-day risk of both events. A daily dashboard report identifies all patients as high, intermediate, or low risk. These dashboard risk scores are then used to proactively manage patients with referrals to services such as social work, dietitian, or evaluation for possible home care assistance. Ultimately, this QI initiative effort will allow proactive management of patients within 30 days of their outpatient chemotherapy—the OP 35 bundling payment initiative that CMS put into effect this year under its Hospital Outpatient Quality Reporting Program.
This session includes a 30 minute discussion with the Innovator Award winner and the program champion, Jay Carlson, DO, Mercy Ministry Oncology Specialty Council, about the process to procure leadership buy-in and dedicated resources for this program.
Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs
Ali McBride, PharmD, MS, BCOP, Clinical Coordinator, Hematology/Oncology
Daniel Persky, MD, Associate Director, Clinical Investigators; Therapeutic Development Program
University of Arizona Cancer Center, Banner University Medical Center Tucson
At the University of Arizona Cancer Center, Banner University Medical Center Tucson, a multidisciplinary team of physicians, pharmacy staff, finance specialists, social workers, nursing staff, and information technologists first identified chemotherapy regimens administered in the inpatient setting that could be safely administered in the outpatient setting, and then implemented a transition plan that included provider and patient education. Benefits included reduced inpatient medical resources and chemotherapy costs, decreased inpatient bed stay, lower infection rates, improved quality of life, and decreased overall cost of care—conservatively estimated at almost $6 million.
This session includes a 30 minute discussion with the Innovator Award winner and the program champion, Daniel Persky, MD, Associate Director, Clinical Investigators; Therapeutic Development Program, about the process to procure leadership buy-in and dedicated resources for this program.
Integration of Prehabilitation, Rehabilitation and Prospective Surveillance Into Cancer Interdisciplinary Teams
Christopher Wilson, PT, DPT, DScPT, Residency Director, Oncologic Rehabilitation
Reyna Colombo, PT, MA, Director of Rehabilitation Services
Beaumont Health System, Beaumont Cancer Institute
Learn how Beaumont Cancer Institute implemented these services and improved the patient experience, reduced hospital length of stay, and facilitated early identification of physical impairments, functional limitations, and/or treatment restrictions. Other key outcomes include reduction of cancer-related fatigue, lymphedema, and falls, and non-opioid pain management. Then hear about the important role rehabilitation played in palliative care for patients with advanced cancer by optimizing quality of remaining life and minimizing unwarranted hospital readmissions. Patient case-based scenarios and video vignettes demonstrate how to integrate and sustain these services into cancer care, including necessary training for team members.
This session includes a 30 minute discussion with the Innovator Award winners and the program champion, Jannifer Stromberg, MD, Medical Director, Wilson Cancer Resource Center; Clinical Assistant Professor, Oakland University William Beaumont School of Medicine, Department of Radiation Oncology; Attending Physician of Radiation Oncology, about the process to procure leadership buy-in and dedicated resources for this program.
A New Treatment for Patients with Relapsed or Refractory Follicular Lymphoma
Lori A. Leslie, MD, Lymphoma/CLL Attending Physician, Director, Indolent Lymphoma and CLL Research Programs, John Theurer Cancer Center, Hackensack Meridian Health.
This session is sponsored by Epizyme.
Implementing Value-Based Outpatient Cancer Rehabilitation Services in Your Backyard
Pete Manning, MBA, Senior Vice President, ReVital Cancer Rehabilitation
Tiffany Kendig, PT, DPT, MPH, CLT, Program Director, ReVital Cancer Rehabilitation
This session is sponsored by ReVital Cancer Rehabilitation.
Alternative Payment Models Coalition Workshop
As part of ACCC’s new Alternative Payment Models Coalition, this three-hour virtual workshop will take a deep dive into the current landscape of alternative payment models - including OCMs, MIPS, ACOs, and more - to address concerns about lack of preparation to perform in these payment models, patient and provider access to the latest treatments, infrastructure considerations, and long-term sustainability. Participants can expect to learn from experts in the field, as well as their peers, through a program which will incorporate didactic presentations and interactive breakout sessions.